RESUMO
PURPOSE: How modern cardiac sparing techniques and beam delivery systems using advanced x-ray and proton beam therapy (PBT) can reduce incidental radiation exposure doses to cardiac and pulmonary organs individually or in any combination is poorly investigated. METHODS: Among 15 patients with left-sided breast cancer, partial wide tangential 3D-conformal radiotherapy (3DCRT) delivered in conventional fractionation (CF) or hypofractionated (HF) schedules; PBT delivered in a CF schedule; and volumetric modulated arc therapy (VMAT) delivered in an HF schedule, each under continuous positive airway pressure (CPAP) and free-breathing (FB) conditions, were examined. Target volume coverage and doses to organs-at-risk (OARs) were calculated for each technique. Outcomes were compared with one-way analysis of variance and the Bonferroni test, with p-values <0.05 considered significant. RESULTS: Target volume coverage was within acceptable levels in all interventions, except for the internal mammary lymph node D95 (99% in PBT, 90% in VMAT-CPAP, 84% in VMAT-FB, and 74% in 3DCRT). The mean heart dose (MHD) was the lowest in PBT (<1 Gy) and VMAT-CPAP (2.2 Gy) and the highest in 3DCRT with CF/FB (7.8 Gy), respectively. The mean lung dose (MLD) was the highest in 3DCRT-CF-FB (20 Gy) and the lowest in both VMAT-HF-CPAP and PBT (approximately 5-6 Gy). VMAT-HF-CPAP and PBT delivered a comparable maximum dose to the left ascending artery (7.2 and 6.13 Gy, respectively). CONCLUSIONS: Both proton and VMAT in combination with CPAP can minimize the radiation exposure to heart and lung with optimal target coverage in regional RT for left-sided breast cancer. The clinical relevance of these differences is yet to be elucidated. Continued efforts are needed to minimize radiation exposures during RT treatment to maximize its therapeutic index.
RESUMO
PURPOSE: To present a fully automated treatment planning process for proton therapy including beam angle selection using a novel Bayesian optimization approach and previously developed constrained hierarchical fluence optimization method. METHODS: We adapted our in-house automated intensity modulated radiation therapy (IMRT) treatment planning system, which is based on constrained hierarchical optimization and referred to as ECHO (expedited constrained hierarchical optimization), for proton therapy. To couple this to beam angle selection, we propose using a novel Bayesian approach. By integrating ECHO with this Bayesian beam selection approach, we obtain a fully automated treatment planning framework including beam angle selection. Bayesian optimization is a global optimization technique which only needs to search a small fraction of the search space for slowly varying objective functions (i.e., smooth functions). Expedited constrained hierarchical optimization is run for some initial beam angle candidates and the resultant treatment plan for each beam configuration is rated using a clinically relevant treatment score function. Bayesian optimization iteratively predicts the treatment score for not-yet-evaluated candidates to find the best candidate to be optimized next with ECHO. We tested this technique on five head-and-neck (HN) patients with two coplanar beams. In addition, tests were performed with two noncoplanar and three coplanar beams for two patients. RESULTS: For the two coplanar configurations, the Bayesian optimization found the optimal beam configuration after running ECHO for, at most, 4% of all potential configurations (23 iterations) for all patients (range: 2%-4%). Compared with the beam configurations chosen by the planner, the optimal configurations reduced the mandible maximum dose by 6.6 Gy and high dose to the unspecified normal tissues by 3.8 Gy, on average. For the two noncoplanar and three coplanar beam configurations, the algorithm converged after 45 iterations (examining <1% of all potential configurations). CONCLUSIONS: A fully automated and efficient treatment planning process for proton therapy, including beam angle optimization was developed. The algorithm automatically generates high-quality plans with optimal beam angle configuration by combining Bayesian optimization and ECHO. As the Bayesian optimization is capable of handling complex nonconvex functions, the treatment score function which is used in the algorithm to evaluate the dose distribution corresponding to each beam configuration can contain any clinically relevant metric.